JP2010524975A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524975A5 JP2010524975A5 JP2010504313A JP2010504313A JP2010524975A5 JP 2010524975 A5 JP2010524975 A5 JP 2010524975A5 JP 2010504313 A JP2010504313 A JP 2010504313A JP 2010504313 A JP2010504313 A JP 2010504313A JP 2010524975 A5 JP2010524975 A5 JP 2010524975A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- hydrogen
- propan
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 131
- 229910052739 hydrogen Inorganic materials 0.000 claims 131
- 239000001257 hydrogen Substances 0.000 claims 129
- 150000002431 hydrogen Chemical class 0.000 claims 67
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 62
- 125000004452 carbocyclyl group Chemical group 0.000 claims 48
- 229910052736 halogen Inorganic materials 0.000 claims 43
- 150000002367 halogens Chemical class 0.000 claims 43
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 38
- PIGFYZPCRLYGLF-UHFFFAOYSA-N Aluminum nitride Chemical compound [Al]#N PIGFYZPCRLYGLF-UHFFFAOYSA-N 0.000 claims 35
- 125000000623 heterocyclic group Chemical group 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 21
- 125000005843 halogen group Chemical group 0.000 claims 19
- 125000003118 aryl group Chemical group 0.000 claims 17
- 208000017442 Retinal disease Diseases 0.000 claims 16
- 239000000203 mixture Substances 0.000 claims 13
- 229910052757 nitrogen Inorganic materials 0.000 claims 12
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 11
- 125000001153 fluoro group Chemical group F* 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 210000001525 retina Anatomy 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 7
- -1 3-hydroxy-5-[(1E) -2- (4-hydroxyphenyl) ethenyl] phenyl ester Chemical class 0.000 claims 6
- 206010057430 Retinal injury Diseases 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 208000035475 disorder Diseases 0.000 claims 6
- 208000030533 eye disease Diseases 0.000 claims 6
- 239000000651 prodrug Substances 0.000 claims 6
- 229940002612 prodrug Drugs 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- 150000001204 N-oxides Chemical class 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 5
- 230000002207 retinal effect Effects 0.000 claims 5
- WPWFMRDPTDEJJA-FAXVYDRBSA-N N-retinylidene-N-retinylethanolamine Chemical group C=1C(\C=C\C=C(/C)\C=C\C=2C(CCCC=2C)(C)C)=CC=[N+](CCO)C=1\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C WPWFMRDPTDEJJA-FAXVYDRBSA-N 0.000 claims 4
- 206010038923 Retinopathy Diseases 0.000 claims 4
- 150000001721 carbon Chemical group 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 208000028867 ischemia Diseases 0.000 claims 4
- 208000002780 macular degeneration Diseases 0.000 claims 4
- 239000000049 pigment Substances 0.000 claims 4
- 210000000880 retinal rod photoreceptor cell Anatomy 0.000 claims 4
- 125000005809 3,4,5-trimethoxyphenyl group Chemical group [H]C1=C(OC([H])([H])[H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 3
- 208000022758 Sorsby fundus dystrophy Diseases 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims 3
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 claims 3
- 125000005504 styryl group Chemical group 0.000 claims 3
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 claims 2
- OQKSTWHBLYTRLR-MDZDMXLPSA-N 2-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]ethanamine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCN)=C1 OQKSTWHBLYTRLR-MDZDMXLPSA-N 0.000 claims 2
- GDKGYVQAUIRZBX-VAWYXSNFSA-N 3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]prop-2-yn-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C#CCN)=C1 GDKGYVQAUIRZBX-VAWYXSNFSA-N 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 208000032578 Inherited retinal disease Diseases 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- 208000035719 Maculopathy Diseases 0.000 claims 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 2
- 206010061876 Obstruction Diseases 0.000 claims 2
- 206010061323 Optic neuropathy Diseases 0.000 claims 2
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 206010038848 Retinal detachment Diseases 0.000 claims 2
- 208000032430 Retinal dystrophy Diseases 0.000 claims 2
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 2
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 2
- 102000004330 Rhodopsin Human genes 0.000 claims 2
- 108090000820 Rhodopsin Proteins 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 2
- 206010064930 age-related macular degeneration Diseases 0.000 claims 2
- 230000033115 angiogenesis Effects 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 230000004300 dark adaptation Effects 0.000 claims 2
- 230000007850 degeneration Effects 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 230000004907 flux Effects 0.000 claims 2
- 201000006321 fundus dystrophy Diseases 0.000 claims 2
- 230000002008 hemorrhagic effect Effects 0.000 claims 2
- 208000014188 hereditary optic neuropathy Diseases 0.000 claims 2
- 210000004276 hyalin Anatomy 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 208000017532 inherited retinal dystrophy Diseases 0.000 claims 2
- 208000038015 macular disease Diseases 0.000 claims 2
- 208000001491 myopia Diseases 0.000 claims 2
- 230000004379 myopia Effects 0.000 claims 2
- 208000020911 optic nerve disease Diseases 0.000 claims 2
- 210000000608 photoreceptor cell Anatomy 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 230000008929 regeneration Effects 0.000 claims 2
- 238000011069 regeneration method Methods 0.000 claims 2
- 230000004264 retinal detachment Effects 0.000 claims 2
- 210000001210 retinal vessel Anatomy 0.000 claims 2
- 150000004492 retinoid derivatives Chemical class 0.000 claims 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- MVNYXEAZKVOLLN-JBVUFVISSA-N (1r)-3-amino-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC([C@H](O)CCN)=C1 MVNYXEAZKVOLLN-JBVUFVISSA-N 0.000 claims 1
- MVNYXEAZKVOLLN-YXBWYFRISA-N (1s)-3-amino-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC([C@@H](O)CCN)=C1 MVNYXEAZKVOLLN-YXBWYFRISA-N 0.000 claims 1
- JNCYMQSTWYVZCF-OZSKJFCKSA-N (1s)-3-amino-1-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]propan-1-ol Chemical compound NCC[C@H](O)C1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 JNCYMQSTWYVZCF-OZSKJFCKSA-N 0.000 claims 1
- IJQYSIVMJQRXLY-ALIVOICLSA-N (2S,3R)-2-amino-3-hydroxy-N-[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]butanamide Chemical compound N[C@H](C(=O)NC1=C(C=CC(=C1)\C=C/C1=CC(=C(C(=C1)OC)OC)OC)OC)[C@@H](C)O IJQYSIVMJQRXLY-ALIVOICLSA-N 0.000 claims 1
- GFQWMSQANCSPPQ-HSBSLETESA-N (2r)-1-amino-3-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]propan-2-ol Chemical compound NC[C@H](O)CC1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 GFQWMSQANCSPPQ-HSBSLETESA-N 0.000 claims 1
- GFQWMSQANCSPPQ-NPQIQWPPSA-N (2s)-1-amino-3-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]propan-2-ol Chemical compound NC[C@@H](O)CC1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 GFQWMSQANCSPPQ-NPQIQWPPSA-N 0.000 claims 1
- RATBBFVZXHSDRR-NJRZHNRPSA-N (2s)-2-amino-n-[2-methoxy-5-[(z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-3-methylbutanamide Chemical compound C1=C(NC(=O)[C@@H](N)C(C)C)C(OC)=CC=C1\C=C/C1=CC(OC)=C(OC)C(OC)=C1 RATBBFVZXHSDRR-NJRZHNRPSA-N 0.000 claims 1
- KNFOKBZURYUWOW-ZEVQVBBLSA-N (2s)-2-amino-n-[2-methoxy-5-[(z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]-4-methylpentanamide Chemical compound C1=C(NC(=O)[C@@H](N)CC(C)C)C(OC)=CC=C1\C=C/C1=CC(OC)=C(OC)C(OC)=C1 KNFOKBZURYUWOW-ZEVQVBBLSA-N 0.000 claims 1
- MYUPODARKKQONN-NPQIQWPPSA-N (2s)-3-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]-2-fluoropropan-1-amine Chemical compound NC[C@@H](F)CC1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 MYUPODARKKQONN-NPQIQWPPSA-N 0.000 claims 1
- ADNOXSJYZLHHRZ-KIRNREEKSA-N (3Z)-3-[3-[2-(2,6-dimethylphenyl)ethenyl]phenyl]-3-hydrazinylidenepropan-1-amine Chemical compound Cc1cccc(C)c1C=Cc1cccc(C(\CCN)=N/N)c1 ADNOXSJYZLHHRZ-KIRNREEKSA-N 0.000 claims 1
- ZAPIUEIQSYXBEM-UOBXZYDMSA-N (3z)-3-hydrazinylidene-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(\CCN)=N/N)=C1 ZAPIUEIQSYXBEM-UOBXZYDMSA-N 0.000 claims 1
- AFAKLPFUAPIXGQ-MBDWYYTESA-N (E)-3-[3-[2-(2,6-dimethylphenyl)ethenyl]phenyl]prop-2-en-1-amine Chemical compound Cc1cccc(C)c1C=Cc1cccc(\C=C\CN)c1 AFAKLPFUAPIXGQ-MBDWYYTESA-N 0.000 claims 1
- CMIVHTLFBIUJTH-MGAHFUHESA-N (NZ)-N-[3-amino-1-[3-[2-(2,6-dimethylphenyl)ethenyl]phenyl]propylidene]hydroxylamine Chemical compound NCC/C(=N/O)/C1=CC(=CC=C1)C=CC1=C(C=CC=C1C)C CMIVHTLFBIUJTH-MGAHFUHESA-N 0.000 claims 1
- WZAMHIIJKHBBSF-ZHACJKMWSA-N (e)-1-[3-(3-aminopropyl)phenyl]-3-ethylpent-1-en-3-ol Chemical compound CCC(O)(CC)\C=C\C1=CC=CC(CCCN)=C1 WZAMHIIJKHBBSF-ZHACJKMWSA-N 0.000 claims 1
- VLSXCDGACFQSQF-PKNBQFBNSA-N (e)-1-[3-(3-aminopropyl)phenyl]-3-methylhex-1-en-3-ol Chemical compound CCCC(C)(O)\C=C\C1=CC=CC(CCCN)=C1 VLSXCDGACFQSQF-PKNBQFBNSA-N 0.000 claims 1
- HEHHAZWIYHQNJM-MDZDMXLPSA-N (e)-1-[3-(3-aminopropyl)phenyl]hex-1-en-3-ol Chemical compound CCCC(O)\C=C\C1=CC=CC(CCCN)=C1 HEHHAZWIYHQNJM-MDZDMXLPSA-N 0.000 claims 1
- JMZLSKWRWCNXSD-BXCLKCLZSA-N (e)-2-fluoro-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]prop-2-en-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(\C=C(\F)CN)=C1 JMZLSKWRWCNXSD-BXCLKCLZSA-N 0.000 claims 1
- XQNSRHAJJXWIKR-XVNBXDOJSA-N (e)-3-[3-(3-aminopropyl)phenyl]prop-2-en-1-ol Chemical compound NCCCC1=CC=CC(\C=C\CO)=C1 XQNSRHAJJXWIKR-XVNBXDOJSA-N 0.000 claims 1
- QQKHNSWZQLKIDO-CMDGGOBGSA-N (e)-4-[3-(3-aminopropyl)phenyl]-2-methylbut-3-en-2-ol Chemical compound CC(C)(O)\C=C\C1=CC=CC(CCCN)=C1 QQKHNSWZQLKIDO-CMDGGOBGSA-N 0.000 claims 1
- CUVAQHRQKYFPLN-KSAPZYQLSA-N (nz)-n-[3-amino-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propylidene]hydroxylamine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(\CCN)=N/O)=C1 CUVAQHRQKYFPLN-KSAPZYQLSA-N 0.000 claims 1
- GZUHDMIETMZNIN-MDZDMXLPSA-N 1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propane-1,3-diamine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(N)CCN)=C1 GZUHDMIETMZNIN-MDZDMXLPSA-N 0.000 claims 1
- LWJFQTAZQWZGON-CCEZHUSRSA-N 1-[3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propyl]piperidine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCCN2CCCCC2)=C1 LWJFQTAZQWZGON-CCEZHUSRSA-N 0.000 claims 1
- ZHRBINGNIDPHQF-BUHFOSPRSA-N 1-[3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propyl]pyrrolidine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCCN2CCCC2)=C1 ZHRBINGNIDPHQF-BUHFOSPRSA-N 0.000 claims 1
- LWJFQTAZQWZGON-PFONDFGASA-N 1-[3-[3-[(z)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propyl]piperidine Chemical compound CC1=CC=CC(C)=C1\C=C/C1=CC=CC(CCCN2CCCCC2)=C1 LWJFQTAZQWZGON-PFONDFGASA-N 0.000 claims 1
- ZHRBINGNIDPHQF-YPKPFQOOSA-N 1-[3-[3-[(z)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propyl]pyrrolidine Chemical compound CC1=CC=CC(C)=C1\C=C/C1=CC=CC(CCCN2CCCC2)=C1 ZHRBINGNIDPHQF-YPKPFQOOSA-N 0.000 claims 1
- PQALEEGHDDHZMT-MDZDMXLPSA-N 1-amino-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-2-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(CC(O)CN)=C1 PQALEEGHDDHZMT-MDZDMXLPSA-N 0.000 claims 1
- KSDLTQDAZDWFKK-ZHACJKMWSA-N 2-[(e)-2-[3-(3-aminopropyl)phenyl]ethenyl]phenol Chemical compound NCCCC1=CC=CC(\C=C\C=2C(=CC=CC=2)O)=C1 KSDLTQDAZDWFKK-ZHACJKMWSA-N 0.000 claims 1
- DRHCFRQFKCNMCN-MDZDMXLPSA-N 2-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenoxy]ethanamine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(OCCN)=C1 DRHCFRQFKCNMCN-MDZDMXLPSA-N 0.000 claims 1
- GOBTZDDLKTZYBH-MDZDMXLPSA-N 2-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]ethanamine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(CCN)=C1 GOBTZDDLKTZYBH-MDZDMXLPSA-N 0.000 claims 1
- JXMWFGDSUMHILQ-MDZDMXLPSA-N 2-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]sulfanylethanamine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(SCCN)=C1 JXMWFGDSUMHILQ-MDZDMXLPSA-N 0.000 claims 1
- CDVGWPIVOINQCB-MDZDMXLPSA-N 2-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]sulfinylethanamine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(S(=O)CCN)=C1 CDVGWPIVOINQCB-MDZDMXLPSA-N 0.000 claims 1
- ONRQGKXNZHJUFA-MDZDMXLPSA-N 2-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]sulfonylethanamine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(S(=O)(=O)CCN)=C1 ONRQGKXNZHJUFA-MDZDMXLPSA-N 0.000 claims 1
- AETORJPTIHURGC-VAWYXSNFSA-N 2-[3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propylamino]ethanol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(CCCNCCO)=C1 AETORJPTIHURGC-VAWYXSNFSA-N 0.000 claims 1
- QSYKFFVERNGYGE-MDZDMXLPSA-N 2-[[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]methylamino]ethanol Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CNCCO)=C1 QSYKFFVERNGYGE-MDZDMXLPSA-N 0.000 claims 1
- RBXQXOPQBYVQIS-MDZDMXLPSA-N 2-amino-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]ethanol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(O)CN)=C1 RBXQXOPQBYVQIS-MDZDMXLPSA-N 0.000 claims 1
- FXWOEVCVWRWPQP-MDZDMXLPSA-N 2-amino-1-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]ethanol Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(C(O)CN)=C1 FXWOEVCVWRWPQP-MDZDMXLPSA-N 0.000 claims 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 1
- FPTVZUBIWQGPBX-MDZDMXLPSA-N 2-amino-n-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]acetamide Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(NC(=O)CN)=C1 FPTVZUBIWQGPBX-MDZDMXLPSA-N 0.000 claims 1
- LCADTYPEALEUAO-ZHACJKMWSA-N 2-methyl-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound NCC(C)CC1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 LCADTYPEALEUAO-ZHACJKMWSA-N 0.000 claims 1
- UNFGQCCHVMMMRF-UHFFFAOYSA-N 2-phenylbutanamide Chemical compound CCC(C(N)=O)C1=CC=CC=C1 UNFGQCCHVMMMRF-UHFFFAOYSA-N 0.000 claims 1
- RDQLTOZPSLWFBC-VAWYXSNFSA-N 3-[2-methyl-5-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=C(C)C(CCCN)=C1 RDQLTOZPSLWFBC-VAWYXSNFSA-N 0.000 claims 1
- SMMRJLXBUXPNJB-VAWYXSNFSA-N 3-[3-[(e)-2-(1-methoxynaphthalen-2-yl)ethenyl]phenyl]propan-1-amine Chemical compound C1=CC2=CC=CC=C2C(OC)=C1\C=C\C1=CC=CC(CCCN)=C1 SMMRJLXBUXPNJB-VAWYXSNFSA-N 0.000 claims 1
- QLLVSACPOAJGDL-MDZDMXLPSA-N 3-[3-[(e)-2-(2,4,6-trimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC(C)=CC(C)=C1\C=C\C1=CC=CC(CCCN)=C1 QLLVSACPOAJGDL-MDZDMXLPSA-N 0.000 claims 1
- HNPWYERMGSZQFN-ZHACJKMWSA-N 3-[3-[(e)-2-(2,5-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC=C(C)C(\C=C\C=2C=C(CCCN)C=CC=2)=C1 HNPWYERMGSZQFN-ZHACJKMWSA-N 0.000 claims 1
- COHVBBAMZSZFSV-ZHACJKMWSA-N 3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]butan-1-amine Chemical compound NCCC(C)C1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 COHVBBAMZSZFSV-ZHACJKMWSA-N 0.000 claims 1
- SQPRVQOLIZOHKE-VAWYXSNFSA-N 3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(CCCN)=C1 SQPRVQOLIZOHKE-VAWYXSNFSA-N 0.000 claims 1
- CICOWLFEHIFHJR-BQYQJAHWSA-N 3-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]-2,2-difluoropropan-1-amine Chemical compound NCC(F)(F)CC1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 CICOWLFEHIFHJR-BQYQJAHWSA-N 0.000 claims 1
- OFLQNOFHNYJMRM-MDZDMXLPSA-N 3-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 OFLQNOFHNYJMRM-MDZDMXLPSA-N 0.000 claims 1
- XXUSALLHYJYAGA-BUHFOSPRSA-N 3-[3-[(e)-2-(2,6-diethoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CCOC1=CC=CC(OCC)=C1\C=C\C1=CC=CC(CCCN)=C1 XXUSALLHYJYAGA-BUHFOSPRSA-N 0.000 claims 1
- CPLRGWJFPLETLO-VAWYXSNFSA-N 3-[3-[(e)-2-(2,6-dimethoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound COC1=CC=CC(OC)=C1\C=C\C1=CC=CC(CCCN)=C1 CPLRGWJFPLETLO-VAWYXSNFSA-N 0.000 claims 1
- FZHPUUJYIQGCKM-OUKQBFOZSA-N 3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]-2-methylphenyl]propan-1-amine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCCN)=C1C FZHPUUJYIQGCKM-OUKQBFOZSA-N 0.000 claims 1
- HELNQALGIJBZCO-MDZDMXLPSA-N 3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]-4-fluorophenyl]propan-1-amine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC(CCCN)=CC=C1F HELNQALGIJBZCO-MDZDMXLPSA-N 0.000 claims 1
- ZAIOJCJMZKCELI-OUKQBFOZSA-N 3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]-n-methylpropan-1-amine Chemical compound CNCCCC1=CC=CC(\C=C\C=2C(=CC=CC=2C)C)=C1 ZAIOJCJMZKCELI-OUKQBFOZSA-N 0.000 claims 1
- ACKOXNPHOJJOLZ-VAWYXSNFSA-N 3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCCN)=C1 ACKOXNPHOJJOLZ-VAWYXSNFSA-N 0.000 claims 1
- YXGPTZZXMXJZIL-BUHFOSPRSA-N 3-[3-[(e)-2-(2-butoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CCCCOC1=CC=CC=C1\C=C\C1=CC=CC(CCCN)=C1 YXGPTZZXMXJZIL-BUHFOSPRSA-N 0.000 claims 1
- QQEMPACAPZMRMY-OUKQBFOZSA-N 3-[3-[(e)-2-(2-ethoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CCOC1=CC=CC=C1\C=C\C1=CC=CC(CCCN)=C1 QQEMPACAPZMRMY-OUKQBFOZSA-N 0.000 claims 1
- PSXPLPCJVGTXNT-OUKQBFOZSA-N 3-[3-[(e)-2-(2-ethyl-6-methylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CCC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCCN)=C1 PSXPLPCJVGTXNT-OUKQBFOZSA-N 0.000 claims 1
- ASCQUHYFSINSDG-ACCUITESSA-N 3-[3-[(e)-2-(2-methoxynaphthalen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound COC1=CC=C2C=CC=CC2=C1\C=C\C1=CC=CC(CCCN)=C1 ASCQUHYFSINSDG-ACCUITESSA-N 0.000 claims 1
- HJUYIUKUUBCIGQ-VAWYXSNFSA-N 3-[3-[(e)-2-(2-methoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound COC1=CC=CC=C1\C=C\C1=CC=CC(CCCN)=C1 HJUYIUKUUBCIGQ-VAWYXSNFSA-N 0.000 claims 1
- LHIMPNFCTKYLTL-VAWYXSNFSA-N 3-[3-[(e)-2-(2-methylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC=CC=C1\C=C\C1=CC=CC(CCCN)=C1 LHIMPNFCTKYLTL-VAWYXSNFSA-N 0.000 claims 1
- VBOJEAGVIKVJIN-FOCLMDBBSA-N 3-[3-[(e)-2-(2-phenylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C=2C(=CC=CC=2)C=2C=CC=CC=2)=C1 VBOJEAGVIKVJIN-FOCLMDBBSA-N 0.000 claims 1
- ZLHZFVLOPXOLJY-CMDGGOBGSA-N 3-[3-[(e)-2-(3,5-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC(C)=CC(\C=C\C=2C=C(CCCN)C=CC=2)=C1 ZLHZFVLOPXOLJY-CMDGGOBGSA-N 0.000 claims 1
- UITGYMASHPKVQS-MDZDMXLPSA-N 3-[3-[(e)-2-(3-chlorophenyl)ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C=2C=C(Cl)C=CC=2)=C1 UITGYMASHPKVQS-MDZDMXLPSA-N 0.000 claims 1
- GGWNYPAAOSIVSI-ZHACJKMWSA-N 3-[3-[(e)-2-(3-methoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound COC1=CC=CC(\C=C\C=2C=C(CCCN)C=CC=2)=C1 GGWNYPAAOSIVSI-ZHACJKMWSA-N 0.000 claims 1
- CYHDTIBJYIKSQN-BQYQJAHWSA-N 3-[3-[(e)-2-(4-methoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound C1=CC(OC)=CC=C1\C=C\C1=CC=CC(CCCN)=C1 CYHDTIBJYIKSQN-BQYQJAHWSA-N 0.000 claims 1
- NGNAJYMEOALPDA-MDZDMXLPSA-N 3-[3-[(e)-2-[2,6-bis(trifluoromethyl)phenyl]ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C=2C(=CC=CC=2C(F)(F)F)C(F)(F)F)=C1 NGNAJYMEOALPDA-MDZDMXLPSA-N 0.000 claims 1
- PJUJZHNFELIJSY-ZHACJKMWSA-N 3-[3-[(e)-2-[2-(trifluoromethyl)phenyl]ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C=2C(=CC=CC=2)C(F)(F)F)=C1 PJUJZHNFELIJSY-ZHACJKMWSA-N 0.000 claims 1
- ORCWBXAPGMTKGI-OUKQBFOZSA-N 3-[3-[(e)-2-cycloheptylethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C2CCCCCC2)=C1 ORCWBXAPGMTKGI-OUKQBFOZSA-N 0.000 claims 1
- FTTGXOXGHQOGFL-VAWYXSNFSA-N 3-[3-[(e)-2-cyclohexylethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C2CCCCC2)=C1 FTTGXOXGHQOGFL-VAWYXSNFSA-N 0.000 claims 1
- USEKNVKYSIYZOO-ZHACJKMWSA-N 3-[3-[(e)-2-cyclopentylethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C\C2CCCC2)=C1 USEKNVKYSIYZOO-ZHACJKMWSA-N 0.000 claims 1
- AZSQWTFLGQISGL-XBXARRHUSA-N 3-[3-[(e)-3-methoxyprop-1-enyl]phenyl]propan-1-amine Chemical compound COC\C=C\C1=CC=CC(CCCN)=C1 AZSQWTFLGQISGL-XBXARRHUSA-N 0.000 claims 1
- YVZJGLCOOBNTSC-RMKNXTFCSA-N 3-[3-[(e)-hept-1-enyl]phenyl]propan-1-amine Chemical compound CCCCC\C=C\C1=CC=CC(CCCN)=C1 YVZJGLCOOBNTSC-RMKNXTFCSA-N 0.000 claims 1
- WZLGJPFVKKGSPB-GZTJUZNOSA-N 3-[3-[(e)-non-4-en-5-yl]phenyl]propan-1-amine Chemical compound CCCC\C(=C/CCC)C1=CC=CC(CCCN)=C1 WZLGJPFVKKGSPB-GZTJUZNOSA-N 0.000 claims 1
- HAQXUGGJYHMFOB-QPJJXVBHSA-N 3-[3-[(e)-pent-1-enyl]phenyl]propan-1-amine Chemical compound CCC\C=C\C1=CC=CC(CCCN)=C1 HAQXUGGJYHMFOB-QPJJXVBHSA-N 0.000 claims 1
- XPVSROPKQGCQNT-QXMHVHEDSA-N 3-[3-[(z)-2-(2,3-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC=CC(\C=C/C=2C=C(CCCN)C=CC=2)=C1C XPVSROPKQGCQNT-QXMHVHEDSA-N 0.000 claims 1
- HAZWTJPUNVFXKC-LUAWRHEFSA-N 3-[3-[(z)-2-(2,4-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC(C)=CC=C1\C=C/C1=CC=CC(CCCN)=C1 HAZWTJPUNVFXKC-LUAWRHEFSA-N 0.000 claims 1
- FZHPUUJYIQGCKM-SEYXRHQNSA-N 3-[3-[(z)-2-(2,6-dimethylphenyl)ethenyl]-2-methylphenyl]propan-1-amine Chemical compound CC1=CC=CC(C)=C1\C=C/C1=CC=CC(CCCN)=C1C FZHPUUJYIQGCKM-SEYXRHQNSA-N 0.000 claims 1
- ZAIOJCJMZKCELI-SEYXRHQNSA-N 3-[3-[(z)-2-(2,6-dimethylphenyl)ethenyl]phenyl]-n-methylpropan-1-amine Chemical compound CNCCCC1=CC=CC(\C=C/C=2C(=CC=CC=2C)C)=C1 ZAIOJCJMZKCELI-SEYXRHQNSA-N 0.000 claims 1
- ACKOXNPHOJJOLZ-QXMHVHEDSA-N 3-[3-[(z)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC=CC(C)=C1\C=C/C1=CC=CC(CCCN)=C1 ACKOXNPHOJJOLZ-QXMHVHEDSA-N 0.000 claims 1
- FCPKJVMGYPHQLU-SEYXRHQNSA-N 3-[3-[(z)-2-(2-ethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CCC1=CC=CC=C1\C=C/C1=CC=CC(CCCN)=C1 FCPKJVMGYPHQLU-SEYXRHQNSA-N 0.000 claims 1
- PSLCOWYOXIZZBN-SEYXRHQNSA-N 3-[3-[(z)-2-(2-ethynylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C/C=2C(=CC=CC=2)C#C)=C1 PSLCOWYOXIZZBN-SEYXRHQNSA-N 0.000 claims 1
- LHIMPNFCTKYLTL-QXMHVHEDSA-N 3-[3-[(z)-2-(2-methylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC1=CC=CC=C1\C=C/C1=CC=CC(CCCN)=C1 LHIMPNFCTKYLTL-QXMHVHEDSA-N 0.000 claims 1
- VJSVUJKPWBEQKS-SEYXRHQNSA-N 3-[3-[(z)-2-(2-propan-2-yloxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC(C)OC1=CC=CC=C1\C=C/C1=CC=CC(CCCN)=C1 VJSVUJKPWBEQKS-SEYXRHQNSA-N 0.000 claims 1
- OUORLZBLDICSNK-SEYXRHQNSA-N 3-[3-[(z)-2-(2-propan-2-ylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CC(C)C1=CC=CC=C1\C=C/C1=CC=CC(CCCN)=C1 OUORLZBLDICSNK-SEYXRHQNSA-N 0.000 claims 1
- ZDQHOHLUNXUQHK-SEYXRHQNSA-N 3-[3-[(z)-2-(2-propoxyphenyl)ethenyl]phenyl]propan-1-amine Chemical compound CCCOC1=CC=CC=C1\C=C/C1=CC=CC(CCCN)=C1 ZDQHOHLUNXUQHK-SEYXRHQNSA-N 0.000 claims 1
- JUUQPSIAQIZOGP-KHPPLWFESA-N 3-[3-[(z)-2-(3,4-dimethylphenyl)ethenyl]phenyl]propan-1-amine Chemical compound C1=C(C)C(C)=CC=C1\C=C/C1=CC=CC(CCCN)=C1 JUUQPSIAQIZOGP-KHPPLWFESA-N 0.000 claims 1
- LGLOMWKWZRFVPM-QXMHVHEDSA-N 3-[3-[(z)-2-(3-methoxynaphthalen-2-yl)ethenyl]phenyl]propan-1-amine Chemical compound COC1=CC2=CC=CC=C2C=C1\C=C/C1=CC=CC(CCCN)=C1 LGLOMWKWZRFVPM-QXMHVHEDSA-N 0.000 claims 1
- JCRJEGIYIWJLQS-SREVYHEPSA-N 3-[3-[(z)-2-(4-chlorophenyl)ethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C/C=2C=CC(Cl)=CC=2)=C1 JCRJEGIYIWJLQS-SREVYHEPSA-N 0.000 claims 1
- ZEVVCNAXJAQWFP-QXMHVHEDSA-N 3-[3-[(z)-2-[2-(2-methoxyethoxy)phenyl]ethenyl]phenyl]propan-1-amine Chemical compound COCCOC1=CC=CC=C1\C=C/C1=CC=CC(CCCN)=C1 ZEVVCNAXJAQWFP-QXMHVHEDSA-N 0.000 claims 1
- NXDBEZGJSOCPAL-YPKPFQOOSA-N 3-[3-[(z)-2-naphthalen-1-ylethenyl]phenyl]propan-1-amine Chemical compound NCCCC1=CC=CC(\C=C/C=2C3=CC=CC=C3C=CC=2)=C1 NXDBEZGJSOCPAL-YPKPFQOOSA-N 0.000 claims 1
- RXVRCNUGGRIQOS-UHFFFAOYSA-N 3-[3-[2-(2,6-dimethylphenyl)ethenyl]phenyl]-3-hydroxypropanimidamide Chemical compound CC1=CC=CC(C)=C1C=CC1=CC=CC(C(O)CC(N)=N)=C1 RXVRCNUGGRIQOS-UHFFFAOYSA-N 0.000 claims 1
- AILVLYLDTGIMED-VQHVLOKHSA-N 3-[5-[(e)-2-(2,6-dichlorophenyl)ethenyl]-2-methoxyphenyl]propan-1-amine Chemical compound C1=C(CCCN)C(OC)=CC=C1\C=C\C1=C(Cl)C=CC=C1Cl AILVLYLDTGIMED-VQHVLOKHSA-N 0.000 claims 1
- QCFDVSIWQVALQQ-CSKARUKUSA-N 3-[5-[(e)-2-(2-chloro-6-methylsulfanylphenyl)ethenyl]-2-methoxyphenyl]propan-1-amine Chemical compound C1=C(CCCN)C(OC)=CC=C1\C=C\C1=C(Cl)C=CC=C1SC QCFDVSIWQVALQQ-CSKARUKUSA-N 0.000 claims 1
- MVNYXEAZKVOLLN-MDZDMXLPSA-N 3-amino-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(O)CCN)=C1 MVNYXEAZKVOLLN-MDZDMXLPSA-N 0.000 claims 1
- BUUMFQMGBUREOX-MDZDMXLPSA-N 3-amino-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-one Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(=O)CCN)=C1 BUUMFQMGBUREOX-MDZDMXLPSA-N 0.000 claims 1
- JNCYMQSTWYVZCF-BQYQJAHWSA-N 3-amino-1-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]propan-1-ol Chemical compound NCCC(O)C1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 JNCYMQSTWYVZCF-BQYQJAHWSA-N 0.000 claims 1
- IXEDDGWFONXBHR-BQYQJAHWSA-N 3-amino-1-[3-[(e)-2-(2,6-dichlorophenyl)ethenyl]phenyl]propan-1-one Chemical compound NCCC(=O)C1=CC=CC(\C=C\C=2C(=CC=CC=2Cl)Cl)=C1 IXEDDGWFONXBHR-BQYQJAHWSA-N 0.000 claims 1
- SCVHVGHEAYRPBI-CMDGGOBGSA-N 3-amino-1-[3-[(e)-2-(2-chloro-6-methylphenyl)ethenyl]phenyl]propan-1-ol Chemical compound CC1=CC=CC(Cl)=C1\C=C\C1=CC=CC(C(O)CCN)=C1 SCVHVGHEAYRPBI-CMDGGOBGSA-N 0.000 claims 1
- FALVZABGRYNOON-VAWYXSNFSA-N 3-amino-2,2-dimethyl-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(O)C(C)(C)CN)=C1 FALVZABGRYNOON-VAWYXSNFSA-N 0.000 claims 1
- RBRQNNZLCPSMMQ-VAWYXSNFSA-N 3-amino-2,2-dimethyl-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-one Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(=O)C(C)(C)CN)=C1 RBRQNNZLCPSMMQ-VAWYXSNFSA-N 0.000 claims 1
- MPBBVYAEAAQSRC-MDZDMXLPSA-N 3-amino-2-fluoro-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-one Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(=O)C(F)CN)=C1 MPBBVYAEAAQSRC-MDZDMXLPSA-N 0.000 claims 1
- FXKCGXJBFRUOSM-ZHACJKMWSA-N 3-amino-2-methyl-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-ol Chemical compound NCC(C)C(O)C1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 FXKCGXJBFRUOSM-ZHACJKMWSA-N 0.000 claims 1
- OGYCIYIBRQOPIT-ZHACJKMWSA-N 3-amino-2-methyl-1-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-one Chemical compound NCC(C)C(=O)C1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 OGYCIYIBRQOPIT-ZHACJKMWSA-N 0.000 claims 1
- FBSOLVONTKXSJE-MDZDMXLPSA-N 3-fluoro-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(F)CCN)=C1 FBSOLVONTKXSJE-MDZDMXLPSA-N 0.000 claims 1
- SWELBYUDHIFUBI-ZHACJKMWSA-N 3-methoxy-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound NCCC(OC)C1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 SWELBYUDHIFUBI-ZHACJKMWSA-N 0.000 claims 1
- FEYOSYWCENBTJX-VAWYXSNFSA-N 3-methoxy-n-methyl-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]propan-1-amine Chemical compound CNCCC(OC)C1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 FEYOSYWCENBTJX-VAWYXSNFSA-N 0.000 claims 1
- UHFQKWZTHVORII-MDZDMXLPSA-N 4,4,4-trifluoro-3-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]butan-1-amine Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(CCN)C(F)(F)F)=C1 UHFQKWZTHVORII-MDZDMXLPSA-N 0.000 claims 1
- HGAFCTJJXJRDBW-DHZHZOJOSA-N 4-[(e)-2-[3-(2-aminoethoxy)phenyl]ethenyl]heptan-4-ol Chemical compound CCCC(O)(CCC)\C=C\C1=CC=CC(OCCN)=C1 HGAFCTJJXJRDBW-DHZHZOJOSA-N 0.000 claims 1
- YKDDVFPUWDDOOM-JLHYYAGUSA-N 4-[(e)-2-[3-(3-aminopropyl)phenyl]ethenyl]heptan-4-ol Chemical compound CCCC(O)(CCC)\C=C\C1=CC=CC(CCCN)=C1 YKDDVFPUWDDOOM-JLHYYAGUSA-N 0.000 claims 1
- OIOADURUGJUHOS-OUKQBFOZSA-N 4-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]butan-2-amine Chemical compound CC(N)CCC1=CC=CC(\C=C\C=2C(CCCC=2C)(C)C)=C1 OIOADURUGJUHOS-OUKQBFOZSA-N 0.000 claims 1
- IWPIWJMSAYHJPN-VAWYXSNFSA-N 4-[3-[3-[(e)-2-(2,6-dimethylphenyl)ethenyl]phenyl]propyl]morpholine Chemical compound CC1=CC=CC(C)=C1\C=C\C1=CC=CC(CCCN2CCOCC2)=C1 IWPIWJMSAYHJPN-VAWYXSNFSA-N 0.000 claims 1
- UOKDLUNJHPODHZ-MDZDMXLPSA-N 4-amino-1,1,1-trifluoro-2-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]butan-2-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(O)(CCN)C(F)(F)F)=C1 UOKDLUNJHPODHZ-MDZDMXLPSA-N 0.000 claims 1
- KHMHQHSWFSLHTL-ZHACJKMWSA-N 4-amino-2-[3-[(e)-2-(2,6,6-trimethylcyclohexen-1-yl)ethenyl]phenyl]butan-2-ol Chemical compound CC1(C)CCCC(C)=C1\C=C\C1=CC=CC(C(C)(O)CCN)=C1 KHMHQHSWFSLHTL-ZHACJKMWSA-N 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- 208000034189 Sclerosis Diseases 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- QCRFMSUKWRQZEM-UHFFFAOYSA-N cycloheptanol Chemical compound OC1CCCCCC1 QCRFMSUKWRQZEM-UHFFFAOYSA-N 0.000 claims 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 210000001116 retinal neuron Anatomy 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91324107P | 2007-04-20 | 2007-04-20 | |
| US60/913,241 | 2007-04-20 | ||
| US93700207P | 2007-06-22 | 2007-06-22 | |
| US60/937,002 | 2007-06-22 | ||
| PCT/US2008/061073 WO2008131368A2 (en) | 2007-04-20 | 2008-04-21 | Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010524975A JP2010524975A (ja) | 2010-07-22 |
| JP2010524975A5 true JP2010524975A5 (OSRAM) | 2012-04-05 |
| JP5371953B2 JP5371953B2 (ja) | 2013-12-18 |
Family
ID=39876187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010504313A Expired - Fee Related JP5371953B2 (ja) | 2007-04-20 | 2008-04-21 | 眼の疾患及び障害を治療するスチレニル誘導体化合物 |
Country Status (16)
| Country | Link |
|---|---|
| US (7) | US20090170841A1 (OSRAM) |
| EP (1) | EP2076124A4 (OSRAM) |
| JP (1) | JP5371953B2 (OSRAM) |
| KR (2) | KR20120137513A (OSRAM) |
| CN (1) | CN101686665B (OSRAM) |
| AU (1) | AU2008242626B2 (OSRAM) |
| BR (1) | BRPI0810063A2 (OSRAM) |
| CA (1) | CA2681850C (OSRAM) |
| CO (1) | CO6251201A2 (OSRAM) |
| EC (1) | ECSP099695A (OSRAM) |
| IL (1) | IL201285A (OSRAM) |
| MX (1) | MX2009011360A (OSRAM) |
| MY (1) | MY161818A (OSRAM) |
| RU (1) | RU2494089C2 (OSRAM) |
| WO (1) | WO2008131368A2 (OSRAM) |
| ZA (1) | ZA200907313B (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101686665B (zh) | 2007-04-20 | 2014-04-23 | 奥克塞拉有限公司 | 用于治疗眼科疾病和紊乱的苯乙烯基衍生化合物 |
| MX2010004718A (es) | 2007-11-01 | 2010-07-28 | Acucela Inc | Compuestos derivados de amina para tratar enfermedades y trastornos oftalmicos. |
| EP2340242A4 (en) | 2008-10-22 | 2012-04-04 | Acucela Inc | COMPOUNDS FOR THE TREATMENT OF EYE DISEASES AND DRESSES |
| WO2012150208A1 (de) | 2011-05-04 | 2012-11-08 | Bayer Cropscience Ag | Verwendung von substituierten benzylalkoholestern der cyclopropancarbonsäure zur bekämpfung von insektizid-resistenten insekten |
| AU2012346214B2 (en) * | 2011-11-30 | 2017-09-14 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
| CN104703598A (zh) | 2012-01-20 | 2015-06-10 | 奥克塞拉有限公司 | 用于疾病治疗的取代的杂环化合物 |
| TW201406707A (zh) * | 2012-05-04 | 2014-02-16 | Acucela Inc | 用以治療糖尿病性視網膜病變及其他眼部疾病之方法 |
| WO2014002053A1 (en) * | 2012-06-28 | 2014-01-03 | Novartis Ag | Pyrrolidine derivatives and their use as complement pathway modulators |
| WO2014002057A1 (en) * | 2012-06-28 | 2014-01-03 | Novartis Ag | Pyrrolidine derivatives and their use as complement pathway modulators |
| EP2867229B1 (en) * | 2012-06-28 | 2017-07-26 | Novartis AG | Pyrrolidine derivatives and their use as complement pathway modulators |
| JP6155332B2 (ja) * | 2012-06-28 | 2017-06-28 | ノバルティス アーゲー | ピロリジン誘導体、および補体経路調節因子としてのその使用 |
| RU2515502C1 (ru) * | 2012-12-21 | 2014-05-10 | федеральное государственное автономное образовательное учреждение высшего профессионального образования "Московский физико-технический институт (государственный университет) | Поверхностно-активный фотосенсибилизатор, представляющий собой бромид 2-{ 4-[(е)-2-(4-этоксифенил)винил]фенокси} -n, n, n-триметилэтаманамина (с-таб) |
| EP3621945B1 (en) | 2017-05-09 | 2025-12-10 | Ambient Photonics, Inc. | Stilbene derivatives for the treatment of cns and other disorders |
| WO2019103989A1 (en) * | 2017-11-22 | 2019-05-31 | Temple University-Of The Commonwealth System Of Higher Education | Novel functionalized n,n-dialkylamino phenyl ethers and their method of use |
| CN110938003B (zh) * | 2018-09-25 | 2022-11-22 | 新发药业有限公司 | 一种芬戈莫德盐酸盐的制备方法 |
| CN112920081B (zh) * | 2021-02-06 | 2023-01-31 | 许昌学院 | 一种选择性识别次氯酸的荧光探针及其制备方法和应用 |
| WO2024196850A1 (en) * | 2023-03-17 | 2024-09-26 | University Of Southern California | Development of highly fluorogenic styrene probes for visualizing rna in live cells |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB815211A (en) | 1957-08-13 | 1959-06-17 | Bayer Ag | Basic ethers |
| US2566360A (en) * | 1948-08-30 | 1951-09-04 | Schering Corp | Aminoalkyl ethers of pyridyl alkylene aryl compounds |
| CH368181A (de) * | 1956-11-13 | 1963-03-31 | Geigy Ag J R | Verfahren zur Herstellung von N-Aminoalkylderivaten von Azepinen |
| US3095449A (en) * | 1957-08-06 | 1963-06-25 | Bayer Ag | 1-(gamma-dimethylaminopropoxy)-2-alkoxy alkenylbenzenes |
| NL255316A (OSRAM) | 1959-08-28 | |||
| US3746768A (en) * | 1970-10-02 | 1973-07-17 | Scm Corp | Substituted phenyl ethers and thioethers as insect repellents |
| GB1433595A (en) * | 1972-07-06 | 1976-04-28 | Ici Ltd | Alkanolamine derivatives |
| DE2547524A1 (de) * | 1975-10-23 | 1977-04-28 | Bayer Ag | Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4569354A (en) | 1982-03-22 | 1986-02-11 | Boston University | Method and apparatus for measuring natural retinal fluorescence |
| FR2558158B1 (fr) * | 1984-01-13 | 1986-05-16 | Roussel Uclaf | Derives de l'indole ethenyl phenol, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et intermediaires |
| US4861897A (en) * | 1987-06-22 | 1989-08-29 | Ortho Pharmaceutical Corporation | 2-Aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles |
| US5217999A (en) * | 1987-12-24 | 1993-06-08 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Styryl compounds which inhibit EGF receptor protein tyrosine kinase |
| US5141959A (en) * | 1990-09-21 | 1992-08-25 | Bristol-Myers Squibb Company | Isoprenoid phospholipase a2 inhibitors and preparations comprising same |
| WO2001009327A2 (en) | 1999-07-28 | 2001-02-08 | Genentech, Inc. | Method of preventing the injury or death of retinal cells and treating ocular diseases |
| JP3163391B2 (ja) * | 1995-03-07 | 2001-05-08 | 味の素株式会社 | スチルベン誘導体及びそれを含有する制癌剤 |
| TW334418B (en) * | 1995-03-07 | 1998-06-21 | Ajinomoto Kk | Stilbene derivatives and pharmaceutical compositions |
| US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| US6878544B2 (en) | 1996-04-19 | 2005-04-12 | Neurotech Sa | Retinal cell lines with extended life-span and their applications |
| FR2747690B1 (fr) | 1996-04-19 | 1998-06-12 | Neurotech Sa | Lignees immortalisees de cellules retiniennes et leurs applications au traitement de differents troubles primaires ou secondaires ophtalmologiques ou neurologiques |
| US6090624A (en) | 1996-04-19 | 2000-07-18 | Brown University Research Foundation | Immortalized retinal cell lines and their applications |
| ATE418536T1 (de) * | 1996-08-12 | 2009-01-15 | Celgene Corp | Neue immunotherapeutische mittel und deren verwendung in der reduzierung von cytokinenspiegel |
| AUPO235996A0 (en) | 1996-09-16 | 1996-10-10 | Garvan Institute Of Medical Research | Method of cell culture |
| CA2216439A1 (en) | 1996-09-25 | 1998-03-25 | Derek Van Der Kooy | Pharmaceuticals containing retinal stem cells |
| US6713300B1 (en) * | 1997-02-27 | 2004-03-30 | University Of Utah Research Foundation | Nucleic acid and amino acid sequences for ATP-binding cassette transporter and methods of screening for agents that modify ATP-binding cassette transporter |
| AU1996599A (en) | 1997-12-05 | 1999-06-28 | Board Of Trustees Of The Leland Stanford Junior University | Long-term survival and regeneration of central nervous system neurons |
| WO2000040699A2 (en) | 1999-01-05 | 2000-07-13 | Aventis Pharma S.A. | Astrocytes, their preparation and uses thereof |
| EP1107003A1 (en) | 1999-12-09 | 2001-06-13 | Trophos | Methods for screening compounds active on neurons |
| US6406840B1 (en) | 1999-12-17 | 2002-06-18 | Biomosaic Systems, Inc. | Cell arrays and the uses thereof |
| AU2001251083A1 (en) * | 2000-03-31 | 2001-10-15 | Ortho-Mcneil Pharmaceutical, Inc. | Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
| DE10021246A1 (de) | 2000-04-25 | 2001-10-31 | Schering Ag | Substituierte Benzoesäureamide und deren Verwendung als Arzneimittel |
| WO2001083714A2 (en) | 2000-05-02 | 2001-11-08 | Central Institute For The Deaf | Composition and methods for treating photoreceptor degeneration |
| US20020009713A1 (en) * | 2000-05-11 | 2002-01-24 | Miller Freda D. | Methods for identifying modulators of neuronal growth |
| WO2002050007A2 (en) * | 2000-12-21 | 2002-06-27 | Cancer Research Technology Limited | Substituted stilbenes, their reactions and anticancer activity |
| US20030032078A1 (en) * | 2001-01-23 | 2003-02-13 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of macular and retinal degenerations |
| DE10141018A1 (de) * | 2001-08-22 | 2003-03-13 | Eth Zuerich Eidgenoessische Te | Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges |
| EP1438281A4 (en) * | 2001-10-26 | 2006-04-26 | Oxigene Inc | FUNCTIONALIZED STILBENE DERIVATIVES USEFUL AS IMPROVED VASCULAR TARGETING AGENTS |
| WO2004000302A1 (en) * | 2002-06-25 | 2003-12-31 | Raju Gokaraju Ganga | Novel resveratrol analogs |
| US7312025B2 (en) * | 2002-07-12 | 2007-12-25 | University Of Washington | Methods and systems for extended in vitro culture of neuronal cells |
| CA2505608A1 (en) * | 2002-12-06 | 2004-06-24 | Alcon, Inc. | Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| KR100730267B1 (ko) * | 2002-12-19 | 2007-06-20 | 화이자 인코포레이티드 | 안과 질환 치료에 유용한 단백질 키나제 저해제로서의2-(1ｈ-인다졸-6-일아미노)-벤즈아미드 화합물 |
| JP3793759B2 (ja) | 2003-03-07 | 2006-07-05 | 憲敬 谷水 | 有孔パネル構体及びその製造方法 |
| WO2004089360A1 (en) * | 2003-04-02 | 2004-10-21 | Taigen Biotechnology | Polyamine compounds for treating chemokine receptor mediated diseases |
| US20050074497A1 (en) * | 2003-04-09 | 2005-04-07 | Schultz Clyde L. | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
| EP1625112B1 (en) * | 2003-05-14 | 2009-07-22 | High Point Pharmaceuticals, LLC | Novel compounds for treatment of obesity |
| US20050059148A1 (en) | 2003-07-30 | 2005-03-17 | Acucela, Inc. | Extended primary retinal cell culture and stress models, and methods of use |
| WO2005025498A2 (en) * | 2003-09-08 | 2005-03-24 | Corus Pharma | Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation |
| TW200529812A (en) | 2003-12-26 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Benzamide derivatives |
| US7706863B2 (en) * | 2004-01-21 | 2010-04-27 | University Of Washington | Methods for assessing a physiological state of a mammalian retina |
| US7566808B2 (en) * | 2004-02-17 | 2009-07-28 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
| RU2006133300A (ru) * | 2004-02-17 | 2008-03-27 | Президент Энд Феллоуз Оф Гарвард Колледж (Us) | Управление течением офтальмологических расстройств, включая дегенерацию желтого пятна |
| JP2007525496A (ja) * | 2004-02-17 | 2007-09-06 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 黄班変性症を含む眼科疾患の管理 |
| EP2397131B1 (en) * | 2004-06-18 | 2019-09-11 | University of Washington | Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| DE102004034957A1 (de) * | 2004-07-16 | 2006-02-02 | Carl Zeiss Jena Gmbh | Anordnung zur mikroskopischen Beobachtung und/oder Detektion und Verwendung |
| CN102240278A (zh) * | 2004-12-08 | 2011-11-16 | 矫正诊疗公司 | 治疗与视黄醇有关的疾病的方法、分析和组合物 |
| CA2642927A1 (en) * | 2005-02-24 | 2006-08-31 | University Of Washington | Methods for treatment of retinal degenerative disease |
| US8098907B2 (en) | 2005-07-01 | 2012-01-17 | Siemens Corporation | Method and system for local adaptive detection of microaneurysms in digital fundus images |
| WO2007089673A2 (en) | 2006-01-26 | 2007-08-09 | Acucela, Inc. | Compositions and methods for treatment of ophthalmic diseases and disorders |
| CN100398624C (zh) | 2006-03-24 | 2008-07-02 | 大连理工大学 | 高分子配位接枝的碱土铝酸盐长余辉发光材料及制备方法 |
| CN101686665B (zh) * | 2007-04-20 | 2014-04-23 | 奥克塞拉有限公司 | 用于治疗眼科疾病和紊乱的苯乙烯基衍生化合物 |
-
2008
- 2008-04-21 CN CN200880021041.1A patent/CN101686665B/zh not_active Expired - Fee Related
- 2008-04-21 JP JP2010504313A patent/JP5371953B2/ja not_active Expired - Fee Related
- 2008-04-21 MY MYPI20094213A patent/MY161818A/en unknown
- 2008-04-21 AU AU2008242626A patent/AU2008242626B2/en not_active Ceased
- 2008-04-21 US US12/107,040 patent/US20090170841A1/en not_active Abandoned
- 2008-04-21 KR KR1020127030994A patent/KR20120137513A/ko not_active Withdrawn
- 2008-04-21 BR BRPI0810063-2A2A patent/BRPI0810063A2/pt not_active IP Right Cessation
- 2008-04-21 WO PCT/US2008/061073 patent/WO2008131368A2/en not_active Ceased
- 2008-04-21 KR KR1020097024142A patent/KR101368248B1/ko not_active Expired - Fee Related
- 2008-04-21 CA CA2681850A patent/CA2681850C/en not_active Expired - Fee Related
- 2008-04-21 RU RU2009136911/04A patent/RU2494089C2/ru not_active IP Right Cessation
- 2008-04-21 EP EP08746483A patent/EP2076124A4/en not_active Withdrawn
- 2008-04-21 MX MX2009011360A patent/MX2009011360A/es active IP Right Grant
-
2009
- 2009-10-01 IL IL201285A patent/IL201285A/en not_active IP Right Cessation
- 2009-10-16 EC EC2009009695A patent/ECSP099695A/es unknown
- 2009-10-19 ZA ZA2009/07313A patent/ZA200907313B/en unknown
- 2009-10-20 CO CO09117150A patent/CO6251201A2/es not_active Application Discontinuation
-
2012
- 2012-01-27 US US13/360,285 patent/US8420863B2/en not_active Expired - Fee Related
-
2013
- 2013-03-07 US US13/789,259 patent/US8653142B2/en not_active Expired - Fee Related
-
2015
- 2015-02-25 US US14/630,889 patent/US9314467B2/en not_active Expired - Fee Related
- 2015-02-25 US US14/631,711 patent/US10201545B2/en active Active
- 2015-02-25 US US14/630,897 patent/US9421210B2/en not_active Expired - Fee Related
-
2016
- 2016-03-16 US US15/072,250 patent/US20160193160A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010524975A5 (OSRAM) | ||
| RU2009136911A (ru) | Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств | |
| JP2012515166A5 (OSRAM) | ||
| JP2021502323A5 (OSRAM) | ||
| JP2013542929A5 (OSRAM) | ||
| JP2010526145A5 (OSRAM) | ||
| RU2006107653A (ru) | Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли | |
| RU2009148137A (ru) | Соединения, представляющие собой алкинилфенильные производные, для лечения офтальмических заболеваний и расстройств | |
| TW555735B (en) | Diarylpropylamines, methods for their preparation and pharmaceutical compositions containing them | |
| JP2004506718A5 (OSRAM) | ||
| JP2020502047A5 (OSRAM) | ||
| RU2010122261A (ru) | Производные амина и их применение для лечения офтальмологических заболеваний и расстройств | |
| JP2011504485A5 (OSRAM) | ||
| JP2014051526A5 (OSRAM) | ||
| JP2011509916A5 (OSRAM) | ||
| JP2009541270A5 (OSRAM) | ||
| JP2020506171A5 (OSRAM) | ||
| JP2009527462A5 (OSRAM) | ||
| JP2019501130A5 (OSRAM) | ||
| JP2008510691A5 (OSRAM) | ||
| JP2022141835A5 (OSRAM) | ||
| JP2010530847A5 (OSRAM) | ||
| JP2017505304A5 (OSRAM) | ||
| JP2019527234A5 (OSRAM) | ||
| JP2015511232A5 (OSRAM) |